Cargando…

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Messenger RNA (mRNA) lipid nanoparticle (LNP) vaccines have emerged as an effective vaccination strategy. Although currently applied toward viral pathogens, data concerning the platform’s effectiveness against bacterial pathogens are limited. Here, we developed an effective mRNA-LNP vaccine against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kon, Edo, Levy, Yinon, Elia, Uri, Cohen, Hila, Hazan-Halevy, Inbal, Aftalion, Moshe, Ezra, Assaf, Bar-Haim, Erez, Naidu, Gonna Somu, Diesendruck, Yael, Rotem, Shahar, Ad-El, Nitay, Goldsmith, Meir, Mamroud, Emanuelle, Peer, Dan, Cohen, Ofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2023
Materias:	Biomedicine and Life Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995031/ https://www.ncbi.nlm.nih.gov/pubmed/36888708 http://dx.doi.org/10.1126/sciadv.adg1036

Ejemplares similares

Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells
por: Chatterjee, Sushmita, et al.
Publicado: (2023)

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery
por: Naidu, Gonna Somu, et al.
Publicado: (2023)

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery (Adv. Sci. 19/2023)
por: Naidu, Gonna Somu, et al.
Publicado: (2023)

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017)

Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response
por: Moses, Sarit, et al.
Publicado: (2021)

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023)
por: Tarab‐Ravski, Dana, et al.
Publicado: (2023)

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles
por: Tarab‐Ravski, Dana, et al.
Publicado: (2023)

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model
por: Gur, David, et al.
Publicado: (2018)

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2015)

The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague
por: Tidhar, Avital, et al.
Publicado: (2009)

Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2022)

Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague
por: Zauberman, Ayelet, et al.
Publicado: (2009)

Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
por: Aftalion, Moshe, et al.
Publicado: (2023)

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
por: Levy, Yinon, et al.
Publicado: (2018)

Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures
por: Shifman, Ohad, et al.
Publicado: (2021)

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system
por: Tidhar, Avital, et al.
Publicado: (2019)

Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages
por: Moses, Sarit, et al.
Publicado: (2021)

Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors
por: Granot-Matok, Yasmin, et al.
Publicado: (2023)

Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection
por: Sittner, Assa, et al.
Publicado: (2018)

A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers
por: Shifman, Ohad, et al.
Publicado: (2019)

Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection
por: Israeli, Ofir, et al.
Publicado: (2021)

Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases
por: Aftalion, Moshe, et al.
Publicado: (2021)

Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay
por: Bar-Haim, Erez, et al.
Publicado: (2019)

YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Correction: YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2014)

Correction: Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection
por: Mechaly, Adva, et al.
Publicado: (2021)

Early sensing of Yersinia pestis airway infection by bone marrow cells
por: Vagima, Yaron, et al.
Publicado: (2012)

Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
por: Kon, Edo, et al.
Publicado: (2020)

Anti-Plague Vaccine in the Treatment of Plague
por: Naidu, T. S.
Publicado: (1930)

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
por: Vagima, Yaron, et al.
Publicado: (2020)

Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice
por: Gutman, Hila, et al.
Publicado: (2022)

A Novel Approach to Vaccine Development: Concomitant Pathogen Inactivation and Host Immune Stimulation by Peroxynitrite
por: Rotem, Shahar, et al.
Publicado: (2022)

Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery
por: Das, Riddha, et al.
Publicado: (2023)

Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles
por: Mizrahy, Shoshy, et al.
Publicado: (2017)

Distinct Contribution of the HtrA Protease and PDZ Domains to Its Function in Stress Resilience and Virulence of Bacillus anthracis
por: Israeli, Ma’ayan, et al.
Publicado: (2019)

T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
por: Cohen, Hila, et al.
Publicado: (2022)

MAPt: A Rapid Antibiotic Susceptibility Testing for Bacteria in Environmental Samples as a Means for Bioterror Preparedness
por: Aloni-Grinstein, Ronit, et al.
Publicado: (2020)

P1355: DELIVERY OF THERAPEUTIC RNA TO THE BONE MARROW IN MULTIPLE MYELOMA USING CD38-TARGETED LIPID NANOPARTICLES
por: Tarab-Ravski, Dana, et al.
Publicado: (2023)

The effects of PEGylation on LNP based mRNA delivery to the eye
por: Ryals, Renee C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k7qqeh4t6424v4nl1dc2fppfu